Using new treatments to improve the success of Organ Transplants these companies: BioTransplants (BTRN), MedImmune (MEDI), Protein Design Labs (PDLI) and SangStat Medical (SANG) are leading the market towards new treatments that are making Organ Transplants more successful by making the chances of Organ Rejection slimmer than ever. You might be interested in our broader Biotechnology and Pharmaceutical Lists.
The Organ Transplant Stock List


ABT through PDLI

Let me see a chart at Big Charts

Let me search for more news

No warranty or guarantee is given as to the completeness or thoroughness of these lists.
Please do your own due diligence.

  ( Disclaimer ) ( Contact us ) ( About us ) ( Advertise with us ) ( Search Site )